Mounjaro vs Ozempic for Women Over 40: An Honest Comparison

If you're a woman over 40 researching weight loss medications, you've likely landed on two names: Mounjaro and Ozempic. Maybe your doctor mentioned one, or your friend is having amazing results with the other. The question keeping you up at night is simple: which one is actually better for you?

Here's the honest answer: both are remarkably effective medications, but they work differently, and those differences matter more as we age. Let's break down what you actually need to know.

Understanding the Basics: What Are These Medications?

Both Mounjaro and Ozempic are injectable medications that were originally developed for type 2 diabetes but have become game-changers for weight management. They work by mimicking hormones your body naturally produces to regulate blood sugar and appetite.

Ozempic contains semaglutide, a GLP-1 receptor agonist. It mimics one hormone that tells your brain you're full and slows how quickly food leaves your stomach.

Mounjaro contains tirzepatide, which is a dual-action medication. It activates both GLP-1 receptors (like Ozempic) and GIP receptors, giving it a two-pronged approach to blood sugar control and appetite regulation.

Think of it this way: Ozempic plays one instrument beautifully, while Mounjaro conducts a small orchestra. Both make music, but the complexity differs.

The Weight Loss Question: What Does the Research Show?

Let's be direct about what you're probably most curious about: weight loss results.

In clinical trials, Mounjaro has shown slightly higher average weight loss than Ozempic. Participants on the highest dose of Mounjaro lost an average of 20-22% of their body weight over 72 weeks, while those on Ozempic lost around 15-17% at the highest dose.

But here's what those numbers don't tell you: individual responses vary enormously. Our physicians have seen women over 40 achieve exceptional results with both medications. Some women respond beautifully to semaglutide, while others find tirzepatide more effective for their particular body chemistry.

Why Women Over 40 May Respond Differently

Your body at 45 is not the same as it was at 25, and that's not a failing—it's biology. Hormonal shifts during perimenopause and menopause affect insulin sensitivity, where you store fat, and how easily you lose weight.

Many women over 40 notice that traditional diet and exercise approaches that worked in their 30s suddenly don't budge the scale. This is often because declining estrogen levels change how your body handles glucose and stores abdominal fat.

GLP-1 medications work particularly well during this life stage because they address the metabolic changes happening beneath the surface. They improve insulin sensitivity, which often becomes impaired during perimenopause, and they work on appetite regulation in ways that can override the increased hunger some women experience with hormonal fluctuations.

Side Effects: The Reality Check

No medication is perfect, and anyone promising you otherwise isn't being honest. Both Mounjaro and Ozempic can cause side effects, and being over 40 doesn't necessarily make you more or less susceptible to them.

The most common side effects for both medications include nausea, occasional vomiting, diarrhea, constipation, and fatigue—especially when starting or increasing doses. These typically improve after the first few weeks as your body adjusts.

Some women in our practice report that Mounjaro causes slightly more gastrointestinal side effects initially, possibly because it's working through two receptor pathways instead of one. However, others find it easier to tolerate. There's no universal rule here.

What Our Physicians See in Practice

In clinical practice, we've noticed that women who start slowly and increase doses gradually tend to have fewer side effects with both medications. Eating smaller, more frequent meals and staying well-hydrated makes a meaningful difference.

Some women over 40 also experience temporary hair thinning with rapid weight loss on either medication. This isn't caused by the medication itself but by the caloric deficit and stress on your body from significant weight loss. It typically resolves within a few months, and ensuring adequate protein intake can help.

Dosing and Convenience

Both Mounjaro and Ozempic are once-weekly injections, which most people find manageable once they get past the initial hesitation about needles. The needles are tiny—much smaller than what you might be imagining.

Ozempic starts at 0.25 mg weekly and can be increased gradually up to 2.4 mg (though the 2.4 mg dose is technically Wegovy, which is semaglutide marketed specifically for weight loss).

Mounjaro starts at 2.5 mg weekly and can go up to 15 mg, with dose increases every four weeks based on tolerance and results.

The titration schedule—how quickly you increase your dose—matters tremendously for side effects. Slower is almost always better, especially if you're sensitive to medications or have a history of gastrointestinal issues.

Cost and Access Considerations

Here's where things get complicated. Both brand-name medications are expensive without insurance, often $900-$1,300 per month. Insurance coverage varies wildly, and many plans still don't cover GLP-1 medications for weight loss, even though they're FDA-approved for this purpose.

Compounded versions of these medications—which is what Ozari Health provides—offer a more accessible option at a fraction of the cost. Compounded semaglutide and tirzepatide contain the same active ingredients but are prepared by specialized pharmacies and aren't subject to brand-name pricing.

For Women: Special Considerations After 40

If you're in perimenopause or menopause, talk with your provider about how these medications might interact with hormone replacement therapy if you're using it. The combination is generally safe, but your provider should know everything you're taking.

Also consider that women over 40 often have different weight loss goals than younger women. You might be more interested in reducing cardiovascular risk factors, improving energy levels, or reducing the visceral fat that increases health risks, rather than achieving a specific clothing size. Both medications excel at improving metabolic health markers beyond just the number on the scale.

For Men: What You Should Know

Men often experience faster initial weight loss on GLP-1 medications than women, partly due to higher baseline muscle mass and metabolic rate. However, side effects are equally common regardless of gender.

If you're over 40, paying attention to protein intake and resistance training becomes especially important while on these medications to preserve muscle mass during weight loss. This matters for long-term metabolic health and maintaining strength as you age.

So Which One Should You Choose?

The frustrating but honest answer is: it depends on your individual situation. Some factors to discuss with your provider include your medical history, whether you have type 2 diabetes, how you've responded to medications in the past, and what your insurance covers.

Many physicians start with semaglutide because we have slightly more long-term safety data with it. However, if you don't get the results you're hoping for after several months at an adequate dose, switching to tirzepatide is a reasonable next step.

The best medication is ultimately the one that you tolerate well, that gives you meaningful results, and that you can access consistently and affordably.

From the Ozari Care Team

In our practice, we've found that the most successful patients are those who view these medications as tools that work alongside—not instead of—sustainable lifestyle changes. Whether you choose Mounjaro or Ozempic, focusing on protein-rich meals, regular movement you actually enjoy, and adequate sleep will amplify your results and help you maintain them long-term. The medication opens the door, but you still need to walk through it.

Starting Your Journey

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team — licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 25, 2026